Therefore, the role of NPM1 mutation or other gene mutations, such as IDH1, IDH2 and TET2 et.al, in the response of elderly AML patients to D-CAG needs further in-depth investigation. This evidence concerns the gene TET2 and acute myeloid leukemia.